MAR 03, 2021 7:49 AM PST

Keeping HIV Latent

WRITTEN BY: Nouran Amin

When (HIV) human immunodeficiency virus infects cells, it can go to sleep as opposed to make viral copies of itself—the process is known as latency. However, keeping HIV+ cells latent so it does not cause harm to the host remains a challenge.

900

"The current drug treatments block healthy cells from becoming infected by the virus," said Yiyang Lu, a PhD student in the Dar lab at the University of Illinois Urbana-Champaign. "The latent reservoir poses a bigger problem because it can start producing the virus at any time. Consequently, patients have to remain on antiretroviral therapy all their lives to prevent a viral rebound."

Now, researchers have found a way to use compounds to keep the suppression of HIV+ cells in an ongoing dormant state. The findings were published in the Proceedings of the National Academy of Sciences (PNAS).

"Commercial drug screens usually look at mean gene expression. Instead, we used a drug screen that looks at fluctuations in gene expression. Our screen allowed us to therefore find more compounds that could have been overlooked," Lu said.

Learn more about HIV:

"We implemented a time-series drug screening approach that are less commonly used in other labs," said Roy Dar, an assistant professor of bioengineering at Illinois and faculty member of the Carl R. Woese Institute for Genomic Biology.

"We want to test if these drugs have off-target effects in terms of how many other genes they affect in the host cells," Dar said. "We also want to test these drugs in patient samples to see whether these drugs suppress HIV in them."

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
FEB 24, 2021
Drug Discovery & Development
How Caffeine Changes the Brain?
FEB 24, 2021
How Caffeine Changes the Brain?
Caffeine is the worlds most consumed psychoactive substance which includes coffee, cola or an energy drink. However, res ...
MAR 20, 2021
Drug Discovery & Development
Weekly Insulin for Type 2 Diabetes Proved Effective
MAR 20, 2021
Weekly Insulin for Type 2 Diabetes Proved Effective
A study found that a new once-weekly basal insulin injection holds similar efficacy, safety and lower rate of low blood ...
MAR 30, 2021
Drug Discovery & Development
Common Alzheimer's Drugs Reduce Mortality Rate and Cognitive Decline
MAR 30, 2021
Common Alzheimer's Drugs Reduce Mortality Rate and Cognitive Decline
Researchers from the Karolinska Institute and Umea University in Sweden have found that a commonly recommended group of ...
APR 15, 2021
Drug Discovery & Development
Magic Mushroom Therapy and Antidepressants Produce Similar Results
APR 15, 2021
Magic Mushroom Therapy and Antidepressants Produce Similar Results
In recent years, psilocybin (the psychoactive ingredient in 'magic mushrooms') has gained increasing amounts of ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
JUN 11, 2021
Drug Discovery & Development
Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression
JUN 11, 2021
Laughing Gas Shows Promise in Rapid Relief of Treatment-Resistant Depression
Researchers led by the University of Chicago Medicine and Washington University have found that low doses of laughing ga ...
Loading Comments...